Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance

Author： Imachi Hitomi  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.122, Iss.2, 2010-07, pp. : 395-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells

By            

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1777-1786

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α

By        

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2167-2175

Spandidos Publications

Access to resources Recommend Favorite

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

By Ignatov Atanas  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 457-466

Springer Publishing Company

Access to resources Recommend Favorite

Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen

By          

Oncology Letters, Vol. 6, Iss. 1, 2013-01 ,pp. : 118-124

Spandidos Publications

Access to resources Recommend Favorite

Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling

By Thrane Susan  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite